Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services reports developments in healthcare workforce solutions and staffing services for healthcare organizations across the United States. Recurring updates cover quarterly results, earnings calls, revenue trends, gross margin, cash flow, debt, and outlook commentary across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Company news also tracks travel nurse staffing, labor disruption staffing, allied staffing, international nurse placement, search, managed service provider activity, language services, workforce technology, and market demand from healthcare systems. AMN's common stock trades on the New York Stock Exchange under the symbol AMN.
AMN Healthcare (NYSE:AMN) will hold its second quarter 2026 earnings conference call on Thursday, August 6, 2026, at 5:00 p.m. ET. The company expects to issue its Q2 2026 earnings news release the same day at approximately 4:15 p.m. ET after market close.
Investors can access a live webcast and replay via the AMN Healthcare investor relations website or join by telephone through advance registration or direct dial-in numbers.
AMN Healthcare (NYSE:AMN) announced a strategic partnership with Brightfield to expand healthcare workforce intelligence and market transparency. Brightfield's Talent Data Exchange (TDX) adds independent, third-party labor market data to AMN's proprietary clinical workforce insights, analytics, and real-time intelligence.
The collaboration supports AMN's WorkWise ecosystem, aiming to help health systems benchmark labor rates, validate workforce costs, align stakeholders, optimize workforce mix and spend, and shift from reactive staffing to proactive, data-backed workforce planning across clinical and non-clinical roles.
AMN Healthcare (AMN) appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, effective June 15, 2026.
Willis will lead an integrated commercial organization, while Novak will oversee human resources and AMN's long-term people strategy during its next phase of growth and innovation.
AMN Healthcare (NYSE:AMN) acquired Jaide Health, a real-time, AI-enabled medical interpretation and translation solution. The deal expands AMN Language Services’ support for Limited English Proficiency (LEP) patients across administrative steps before and after care, while keeping medically qualified human interpreters central for clinical, complex, and sensitive conversations.
The Jaide Health platform is already live with clients in multiple healthcare settings, and its team will join AMN Healthcare. Financial terms were not disclosed.
AMN Healthcare (AMN) elected Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership in healthcare services, benefits and insurance.
He previously served as CEO of Evernorth Health Services, leading revenue to over $200 billion, and as CFO of Cigna, where he helped drive the Express Scripts acquisition.
AMN Healthcare (NYSE: AMN) reported Q1 2026 revenue of $1.378 billion and adjusted EBITDA of $166.1 million. GAAP diluted EPS was $1.59; adjusted diluted EPS was $2.10. Nurse and Allied revenue was $1.127 billion, and labor disruption contributed $722 million of revenue.
Cash from operations was $562 million, quarter-end cash was $561 million, and total debt was $750 million. Q2 2026 revenue guidance is $620–$635 million with adjusted EBITDA margin of 6.7%–7.2%.
AMN Healthcare (NYSE: AMN) will report first quarter 2026 results and host a conference call on Thursday, May 7, 2026 at 5:00 p.m. ET. The company expects to issue an earnings release at approximately 4:15 p.m. ET the same day.
A live webcast and telephone participation are available via registration on the investor relations website, with a replay posted after the call. In 2025, AMN’s healthcare professionals reached over 13 million patients across more than 2,300 healthcare systems, including 93% of top systems.
AMN Healthcare (NYSE:AMN) reports a sharp confidence divide: nearly three-quarters of healthcare executives expect their own organizations to be as strong or stronger in 2026, while 52% expect the overall industry to fare worse. The 2026 B.E. Smith survey of 703 executives highlights rising demand for AI leadership (63% prioritize AI strategy) and persistent gaps in succession planning, clinician engagement, recruiting, and promotion pathways.
Key metrics: AI strategy 63%, clinician adoption 48%, data infrastructure 41%, promotion-track 21%, intent-to-leave within one year 35%.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2M and GAAP loss of ($0.20) per share; adjusted EPS was $0.22. Full‑year revenue was $2.730B (down 8%) with a net loss of ($95.7M). Cash flow from operations totaled $269M for 2025 and the company reduced total debt by $285M. First‑quarter 2026 guidance assumes ~$600M of labor disruption revenue, driving Q1 consolidated revenue guidance of $1.225–$1.240B.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2 million (up 2% YoY; +18% sequential) and GAAP loss of ($0.20) per share. Adjusted EPS was $0.22 and adjusted EBITDA was $54.5 million. Full-year 2025 revenue was $2.730 billion (down 8% YoY) with adjusted EPS of $1.36. Cash flow from operations was $76 million for Q4 and $269 million for the year; total debt ended at $775 million with net leverage of 3.3x. First-quarter 2026 revenue guidance is $1.225–$1.240 billion, assuming approximately $600 million of labor disruption revenue.